Skip to content

Exploring the Correlation of Cardiopulmonary Bypass with Post-Cardiac Surgery Intestinal Ischemia/Reperfusion Injury and Gut Microbiota Dysbiosis

Exploring the Correlation of Cardiopulmonary Bypass with Post-Cardiac Surgery Intestinal Ischemia/Reperfusion Injury and Gut Microbiota Dysbiosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095300
Enrollment
Unknown
Registered
2025-01-06
Start date
2025-01-10
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal ischemia/reperfusion injury after cardiopulmonary bypass

Interventions

CPB_A group (The CPB time is less than 60 minutes.):NA
CPB_B group (The CPB time is 60-120 minutes.):NA
CPB_C group (The CPB time is more than 120 minutes.):NA
Control group (Surgery without CPB):NA

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing open-heart surgery under general anesthesia. 2.Patients age range is from 18 to 70. 3.Study participants and their families should be informed about the study and sign consent forms.

Exclusion criteria

Exclusion criteria: 1.Patients who have had acute gastrointestinal disease within the past 3 months. 2.Patients with a history of chronic gastrointestinal disease or gastrointestinal surgery. 3.Patients received potent antibiotics, either as monotherapy with third-generation cephalosporins or carbapenems, or as a combination therapy involving any mix of two or more antibiotics, both prior to surgery and within the week subsequent to the procedure. 4.The patients were diagnosed with systemic diseases before surgery, such as malignant tumor, metabolic syndrome, connective tissue disease, congenital or acquired immune deficiency disease, etc. 5.Patients had severe organ dysfunction before surgery, such as heart, lung, liver, and kidney failure, etc; 6. The patient has a history of chemotherapy and radiotherapy; 7. Pregnant and lactating women; 8. The subjects and their families did not sign the informed consent.

Design outcomes

Primary

MeasureTime frame
FABP2;DAO;MDA;16S rRNA sequencing results of intestinal flora of patients after surgery;IL-6;IL-1ß;LDH;AST;

Secondary

MeasureTime frame
CRP;PCT;AGI Diagnosis Classification;Sequential Organ Failure Assessment;Length of Stay;Duration of Mechanical Ventilation;Duration of Mechanical Ventilation;CK;

Countries

China

Contacts

Public ContactWenjun Zhou

The First Hospital of Lanzhou University,The First Clinical Medical College of Lanzhou University

zwj-1225@163.com+86 138 9326 3804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026